Autologous peripheral blood stem-cell transplantation with a double-conditioning regimen for recurrent hepatoblastoma after liver transplantation--a valid therapeutic option or just too much?--author reply.
Umeda
Katsutsugu
K
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Watanabe
Ken-Ichiro
K
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D006084:Graft Rejection; D018197:Hepatoblastoma / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy; D016031:Liver Transplantation / Q000009:adverse effects; D008495:Medical Oncology / Q000379:methods; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D011379:Prognosis; D012008:Recurrence; D012306:Risk; D016559:Tacrolimus / Q000494:pharmacology; D019172:Transplantation Conditioning / Q000379:methods*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016559:Tacrolimus